GO:0035098 ESC/E(Z) complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0035098 (ESC/E(Z) complex), also known as Polycomb repressive complex 2 (PRC2), is a multimeric histone methyltransferase complex that methylates histone H3 at lysine 27 (H3K27) and lysine 9 (H3K9).
• The complex was first purified from Drosophila and contains core subunits ESC, E(Z), CAF1 (NURF-55), and SU(Z)12; mammalian PRC2 contains EED, EZH2, SUZ12, and RBBP4.
• ESC and E(Z) physically interact and are required for Polycomb group-mediated repression of homeotic genes.
• The ESC/E(Z) complex exists in multiple distinct forms that change dynamically during development, and it can associate with additional factors such as Polycomblike and RPD3.
• The complex participates in developmental signaling pathways, including Hedgehog signaling.
• Dysregulation of ESC/E(Z) complex genes has been linked to premenstrual dysphoric disorder (PMDD), where intrinsic differences in cells from affected women have been observed.
Description
The ESC/E(Z) complex (GO:0035098) is a multimeric protein complex that functions as a histone methyltransferase, catalyzing the methylation of histone H3 at lysine 27 and lysine 9. This complex is the effector of Polycomb group (PcG) silencing, a conserved epigenetic system that represses developmental regulator genes, notably Hox genes, to maintain cell identity and proper body plan. In Drosophila, the core subunits include Extra Sex Combs (ESC), Enhancer of Zeste (E(Z)), CAF1 (NURF-55), and SU(Z)12; in mammals, the core is composed of EED, EZH2, SUZ12, and RBBP4. The complex is also known as Polycomb repressive complex 2 (PRC2). Researchers study GO:0035098 because it is a central epigenetic regulator with broad roles in development, stem cell maintenance, and disease. The catalytic activity of E(Z)/EZH2 deposits H3K27me3, a repressive mark that is recognized by the EED subunit, creating a self-reinforcing loop for spreading silencing. The complex is not a single static entity; it exists in multiple distinct complexes that undergo dynamic changes during development, and it can associate with accessory proteins such as Polycomblike and the histone deacetylase RPD3. Beyond development, the ESC/E(Z) complex has been implicated in signaling pathways such as Hedgehog and in steroid-responsive processes. For example, the complex acts as an effector of ovarian steroid response, and intrinsic differences in cells from women with premenstrual dysphoric disorder have been reported. These findings highlight the complex as a node integrating epigenetic regulation with environmental and hormonal signals.
ESC/E(Z) complex At A Glance
| GO ID | GO:0035098 |
|---|---|
| GO term | ESC/E(Z) complex |
| Ontology | cellular_component |
| Synonym | Extra Sex Combs/Enhancer of Zeste complex; polycomb repressive complex 2; PRC2 complex |
| Major function | Histone H3 lysine-27 and lysine-9 methylation; Polycomb group-mediated transcriptional repression |
| Core subunits (Drosophila) | ESC, E(Z), CAF1 (NURF-55), SU(Z)12 |
| Core subunits (mammals) | EED, EZH2, SUZ12, RBBP4 |
| Associated factors | Polycomblike, RPD3 |
| Developmental dynamics | Present in multiple distinct complexes that change during development |
What Is GO:0035098?
GO:0035098 (ESC/E(Z) complex) is a cellular component defined as a multimeric protein complex that can methylate lysine-27 and lysine-9 residues of histone H3. In Drosophila, the core subunits include ESC, E(Z), CAF1 (NURF-55), and SU(Z)12. In mammals, the core subunits include EED, EZH2, SUZ12, and RBBP4. The complex is synonymous with Extra Sex Combs/Enhancer of Zeste complex and Polycomb repressive complex 2 (PRC2).
Why Is ESC/E(Z) complex Important in Cell Biology?
The ESC/E(Z) complex is essential for epigenetic gene silencing and developmental regulation. It deposits repressive histone marks that maintain cell identity and control body patterning. Its dysfunction is linked to human disorders, including premenstrual dysphoric disorder, and it participates in signaling pathways such as Hedgehog. Understanding its composition, assembly, and regulation is therefore critical for both basic developmental biology and disease research.
• Central epigenetic silencer: methylates H3K27 and H3K9 to repress target genes.
• Conserved developmental regulator: controls Hox gene expression and body plan in Drosophila and mammals.
• Exists in multiple dynamic complexes during development, allowing context-specific functions.
• Interacts with accessory proteins such as Polycomblike and RPD3 to modulate repression.
• Participates in Hedgehog signaling, linking epigenetic regulation to developmental pathways.
• Acts as an effector of ovarian steroid response in cells from women with PMDD.
• Associated with differential resting cerebral blood flow regulation in PMDD.
• Provides a model for studying Polycomb group-mediated repression mechanisms.
• Potential target for therapeutic modulation in diseases involving epigenetic dysregulation.
• Key subject for CRISPR-based functional genomics and drug discovery.
Structure and Composition of ESC/E(Z) complex
Core Subunits in Drosophila
In simple terms: The fruit fly version of the complex is built from four main proteins that work together.
In Drosophila, the ESC/E(Z) complex contains the core subunits ESC, E(Z), CAF1 (NURF-55), and SU(Z)12. ESC and E(Z) are direct physical partners and are required for Polycomb group-mediated repression. The complex was purified as a 1-megadalton entity that also contains Polycomblike and RPD3. Covalently modified forms of ESC are present in the complex, suggesting post-translational regulation.
Core Subunits in Mammals
In simple terms: In mammals, the complex uses a similar set of proteins but with different names.
The mammalian ESC/E(Z) complex, also known as PRC2, contains EED, EZH2, SUZ12, and RBBP4. EZH2 is the catalytic subunit that methylates histone H3 at lysine 27. EED and SUZ12 are essential for complex integrity and activity, while RBBP4 contributes to histone binding.
Multiple Complex Forms and Dynamic Changes
In simple terms: The complex is not always the same; its composition changes during development.
ESC and E(Z) are present in multiple distinct complexes that undergo dynamic changes during development. This heterogeneity allows the complex to regulate different target genes at different developmental stages. The association with Polycomblike and RPD3 further diversifies its functions.
Assembly and Stoichiometry
In simple terms: The parts come together in a specific way to form a working machine.
The complex assembles into a multimeric structure with a defined stoichiometry. In Drosophila, the core complex has a mass of approximately 1 megadalton. The catalytic subunit E(Z) requires ESC, SU(Z)12, and CAF1 for full activity and stability. In mammals, the minimal active complex requires EED, EZH2, SUZ12, and RBBP4.
Key Genes Involved in GO:0035098 ESC/E(Z) complex
The following genes encode the core and associated subunits of the ESC/E(Z) complex, as well as related regulatory factors.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EZH2 | Catalytic subunit; methylates H3K27 | Target for epigenetic therapy; frequently mutated in cancers |
| EED | Core subunit; binds H3K27me3 and stimulates EZH2 activity | Essential for complex integrity; feedback regulation |
| SUZ12 | Core subunit; required for complex assembly and activity | Mutations linked to developmental disorders |
| RBBP4 | Core subunit; histone chaperone and chromatin binding | Modulates complex targeting |
| ESC | Drosophila core subunit; binds E(Z) and is required for repression | Model for Polycomb repression |
| E(Z) | Drosophila catalytic subunit; H3K27 methyltransferase | Developmental gene silencing |
| CAF1 (NURF-55) | Drosophila core subunit; chromatin remodeling factor | Complex assembly and function |
| SU(Z)12 | Drosophila core subunit; essential for complex activity | Developmental regulation |
| Polycomblike | Accessory factor in Drosophila complex | Modulates repression |
| RPD3 | Histone deacetylase associated with the complex | Couples deacetylation to methylation |
| EZH1 | Mammalian homolog of EZH2; alternative catalytic subunit | Compensatory roles in PRC2 |
| JARID2 | Accessory factor in mammalian PRC2 | Recruits PRC2 to target genes |
| AEBP2 | Accessory factor in mammalian PRC2 | Stimulates methyltransferase activity |
| PHF1 | Polycomblike homolog in mammals | Regulates PRC2 targeting |
| HDAC1/2 | Histone deacetylases associated with PRC2 | Cooperate with PRC2 in repression |
| H3K27me3 | Repressive histone mark deposited by PRC2 | Epigenetic silencing marker |
| H3K9me3 | Repressive histone mark deposited by PRC2 | Heterochromatin formation |
| Hedgehog | Signaling pathway influenced by ESC/E(Z) complex | Developmental signaling |
How Is ESC/E(Z) complex Regulated?
The ESC/E(Z) complex is regulated at multiple levels. Its catalytic activity is stimulated by the binding of EED to H3K27me3, creating a positive feedback loop for spreading the repressive mark. In Drosophila, the complex exists in multiple forms that change dynamically during development, suggesting developmental regulation of composition. Covalent modification of ESC has been observed, indicating post-translational control. The complex also associates with accessory proteins such as Polycomblike and RPD3, which modulate its targeting and activity. Additionally, the complex acts as an effector of ovarian steroid response, linking hormonal signaling to its function.
ESC/E(Z) complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Cancer (overexpression/mutation) | Knockout and point-mutation cell lines; xenograft models |
| EED | Developmental disorders; cancer | Knock-in of patient mutations; organoids |
| SUZ12 | Developmental disorders | Knockout and knock-in models |
| ESC/E(Z) complex genes | Premenstrual dysphoric disorder | Patient-derived cells; steroid-responsive models |
| Hedgehog pathway | Developmental signaling defects | Drosophila mutants; pathway reporter assays |
Premenstrual Dysphoric Disorder (PMDD)
The ESC/E(Z) complex has been identified as an effector of ovarian steroid response, and cells from women with PMDD show intrinsic differences in complex function. Furthermore, resting regional cerebral blood flow in the subgenual cingulate is differentially regulated by ovarian steroids and is associated with expression of ESC/E(Z) complex genes in PMDD. These findings suggest that the complex mediates hormonal effects on mood and brain function.
Cancer
EZH2, the catalytic subunit of the mammalian ESC/E(Z) complex, is frequently overexpressed or mutated in cancers, leading to aberrant H3K27me3 and silencing of tumor suppressor genes. Targeting the complex is an active area of epigenetic therapy.
Developmental Disorders
Mutations in core subunits such as SUZ12 and EED can disrupt complex assembly and cause developmental abnormalities, underscoring the complex's role in human development.
From ESC/E(Z) complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the catalytic role of EZH2 in H3K27 methylation? | EZH2 knockout cell lines |
| How does EED binding to H3K27me3 stimulate PRC2? | Point mutations in EED aromatic cage; knock-in cells |
| What are the developmental consequences of SUZ12 loss? | SUZ12 knockout mice or Drosophila |
| How does the complex respond to ovarian steroids? | Patient-derived cells with steroid treatment |
| What is the role of ESC/E(Z) in Hedgehog signaling? | Drosophila mutants; Hedgehog reporter assays |
| How does complex composition change during development? | Tagged knock-in of core subunits; proteomics |
How to Study the ESC/E(Z) complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genomic binding of complex subunits and histone marks | Mapping H3K27me3 and target genes |
| Affinity purification + mass spectrometry | Protein composition and interactions | Identifying core and accessory subunits |
| Histone methyltransferase assay | Catalytic activity of EZH2/E(Z) | Testing mutations and inhibitors |
| RNA-seq | Transcriptional changes upon complex perturbation | Gene expression profiling |
| Proximity ligation assay (PLA) | In situ protein-protein interactions | Validating ESC-E(Z) interaction |
| Immunofluorescence | Subcellular localization of complex subunits | Nuclear localization studies |
| CRISPR screening | Functional importance of complex genes | Identifying dependencies in disease models |
Chromatin Immunoprecipitation (ChIP)
ChIP followed by sequencing (ChIP-seq) is used to map the genomic binding sites of ESC/E(Z) complex subunits and the distribution of H3K27me3 and H3K9me3 marks. This method reveals target genes and the spreading of repressive marks.
Proteomics and Complex Purification
Affinity purification coupled with mass spectrometry has been used to identify core subunits and associated factors of the ESC/E(Z) complex, such as Polycomblike and RPD3. This approach defines the composition and stoichiometry of the complex.
Histone Methyltransferase Assays
In vitro methyltransferase assays using recombinant complex subunits and histone substrates measure the catalytic activity of E(Z)/EZH2 and the effects of mutations. These assays are essential for mechanistic studies.
Transcriptomics and Epigenomics
RNA-seq and ChIP-seq are combined to assess how loss or mutation of ESC/E(Z) complex genes affects gene expression and epigenetic landscapes. This is particularly useful for studying steroid-responsive genes in disease models.
How CRISPR Can Be Used to Study GO:0035098 ESC/E(Z) complex
Knockout
CRISPR knockout of core ESC/E(Z) complex genes such as EZH2, EED, SUZ12, or RBBP4 abolishes complex function and H3K27me3 deposition, enabling studies of gene silencing and developmental roles. Knockout cell lines are valuable for drug sensitivity screens and for validating target genes.
Point Mutation
Point mutations can be introduced into catalytic residues of EZH2 or in the EED aromatic cage to dissect the methyltransferase activity and the allosteric activation by H3K27me3. Such models help distinguish catalytic from scaffolding functions.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) into endogenous loci allows for affinity purification and proteomic analysis of the complex under native conditions. Knock-in of disease-associated mutations can model human disorders.
Overexpression
Overexpression of EZH2 or other subunits can mimic oncogenic states and is used to study gain-of-function effects on proliferation and gene expression. Inducible overexpression systems provide temporal control.
How EDITGENE Supports ESC/E(Z) complex Research
Researchers studying ESC/E(Z) complex-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for ESC/E(Z) complex research.
Frequently Asked Questions About ESC/E(Z) complex
What is the ESC/E(Z) complex?
The ESC/E(Z) complex (GO:0035098) is a multimeric histone methyltransferase complex that methylates histone H3 at lysine 27 and lysine 9, also known as Polycomb repressive complex 2 (PRC2).
What genes are involved in the ESC/E(Z) complex?
In Drosophila, core subunits include ESC, E(Z), CAF1 (NURF-55), and SU(Z)12; in mammals, they include EED, EZH2, SUZ12, and RBBP4.
What is the function of the ESC/E(Z) complex?
It deposits repressive histone marks (H3K27me3 and H3K9me3) to silence target genes, thereby regulating development and cell identity.
How is the ESC/E(Z) complex regulated?
Its activity is stimulated by EED binding to H3K27me3, and it is dynamically composed during development; it also associates with accessory proteins like Polycomblike and RPD3.
What diseases are associated with the ESC/E(Z) complex?
It has been linked to premenstrual dysphoric disorder and cancer, among other conditions.
What is the role of EZH2 in the ESC/E(Z) complex?
EZH2 is the catalytic subunit that methylates histone H3 at lysine 27.
How can I study the ESC/E(Z) complex in the lab?
Common methods include ChIP-seq, proteomics, histone methyltransferase assays, and CRISPR-based perturbation.
What model organisms are used to study the ESC/E(Z) complex?
Drosophila melanogaster is a key model, where the complex was first purified and characterized.
What is the difference between PRC2 and the ESC/E(Z) complex?
They are the same entity; PRC2 is the mammalian name for the ESC/E(Z) complex.
How does the ESC/E(Z) complex affect Hedgehog signaling?
The complex participates in the Hedgehog signaling pathway, influencing developmental gene expression.
Conclusion
The ESC/E(Z) complex (GO:0035098) is a conserved epigenetic regulator with essential roles in development and disease. Its core subunits and dynamic assembly have been well characterized, and its dysfunction is linked to conditions such as PMDD and cancer. Continued research using CRISPR-based models will further elucidate its mechanisms and therapeutic potential.
References
- 1. Cao R et al.. 2002. Role of histone H3 lysine 27 methylation in Polycomb-group silencing.. Science 298(5595):1039-43 PMID: 12351676
- 2. Tie F et al.. 2003. A 1-megadalton ESC/E(Z) complex from Drosophila that contains polycomblike and RPD3.. Mol Cell Biol 23(9):3352-62 PMID: 12697833
- 3. Dubey N et al.. 2017. The ESC/E(Z) complex, an effector of response to ovarian steroids, manifests an intrinsic difference in cells from women with premenstrual dysphoric disorder.. Mol Psychiatry 22(8):1172-1184 PMID: 28044059
- 4. Shindo N et al.. 2005. The ESC-E(Z) complex participates in the hedgehog signaling pathway.. Biochem Biophys Res Commun 327(4):1179-87 PMID: 15652519
- 5. Jones CA et al.. 1998. The Drosophila esc and E(z) proteins are direct partners in polycomb group-mediated repression.. Mol Cell Biol 18(5):2825-34 PMID: 9566901
- 6. Ng J et al.. 2000. A Drosophila ESC-E(Z) protein complex is distinct from other polycomb group complexes and contains covalently modified ESC.. Mol Cell Biol 20(9):3069-78 PMID: 10757791
- 7. Furuyama T et al.. 2003. Polycomb group proteins ESC and E(Z) are present in multiple distinct complexes that undergo dynamic changes during development.. Genesis 35(2):114-24 PMID: 12533794
- 8. Wei SM et al.. 2021. Subgenual cingulate resting regional cerebral blood flow in premenstrual dysphoric disorder: differential regulation by ovarian steroids and preliminary evidence for an association with expression of ESC/E(Z) complex genes.. Transl Psychiatry 11(1):206 PMID: 33833224
